Quick Answer
Gain Therapeutics, Inc. reported Total Revenue of $55.2 thousand for fiscal year 2023.
Gain Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $55.2K | -60.6% |
| 2022 | $140.1K | -15.1% |
| 2021 | $165.0K | +471.3% |
| 2020 | $28.9K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $55.2K | +22.6% | -42.0% |
| June 30, 2022 | $95.1K | +6.6% | +111.3% |
| March 31, 2022 | $45.0K | +754.2% | +64.6% |
| September 30, 2021 | $27.3K | +308.4% | -69.3% |
| June 30, 2021 | $89.2K | +1299.2% | +1592.4% |
| March 31, 2021 | $5.3K | -21.0% | -21.3% |
| September 30, 2020 | $6.7K | — | +5.1% |
| June 30, 2020 | $6.4K | — | -4.5% |
- Gain Therapeutics, Inc. showed a decrease of -60.6% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2023 period, Gain Therapeutics, Inc.’s total revenue has grown by 91.1% (from $28.9 thousand to $55.2 thousand).
- The most recent figure is from Gain Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: